Earnings (Loss) per Share

12 Months Ended

Dec. 27, 2024

Earnings (Loss) per Share [Abstract]

Earnings (Loss) per Share

9. Income (loss) per Share

The weighted-average number of shares outstanding used in the computations of both basic and diluted income (loss) per share were as follows (in millions):

	Successor		Predecessor
	Year Ended December 27, 2024	Period from November 15, 2023 through December 29, 2023	Period from December 31, 2022 through November 14, 2023	Period from June 17, 2022 through December 30, 2022	Period from January 1, 2022 through June 16, 2022
Basic	19.7	19.7	13.3	13.2	84.8
Dilutive impact of restricted share units	0.1	—	—	—	—
Diluted	19.8	19.7	13.3	13.2	84.8

The computation of diluted weighted-average shares outstanding for the year ended December 27, 2024 (Successor), period November 15, 2023 through December 29, 2023 (Successor), the period December 31, 2022 through November 14, 2023 (Predecessor), the period June 17, 2022 through December 30, 2022 (Predecessor), and the period January 1, 2022 through June 16, 2022 (Predecessor) excluded approximately 1.7 million, 1.0 million, zero, zero, and 0.5 million shares of Opioid CVRs for the Successor periods only and equity awards for all periods presented, respectively, because the effect would have been anti-dilutive.